Cover Image
市場調查報告書

Pantarhei Bioscience BV:產品平台分析

Pantarhei Bioscience BV - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253718
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
Pantarhei Bioscience BV:產品平台分析 Pantarhei Bioscience BV - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 34 Pages
簡介

Pantarhei Bioscience BV是總公司設立於荷蘭的生物製藥企業,正在開發用於婦科疾病的治療及癌症內分泌療法的醫藥品。該公司的開發中產品有ESTETROL,ZP,ARC,BLACE,OTE-F,TESTETROL等用於乳癌及前列腺癌的荷爾蒙療法。此外同時也包攬專案管理與研究開發活動的外包業務。

本報告提供Pantarhei Bioscience BV的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Pantarhei Bioscience BV的基本資料

  • Pantarhei Bioscience BV概要
  • 主要資訊
  • 企業資料

Pantarhei Bioscience BV:R&D概要

  • 主要的治療範圍

Pantarhei Bioscience BV:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Pantarhei Bioscience BV:開發中產品概況

  • 後期階段產品開發中產品
    • 第Ⅲ相的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第Ⅱ相的產品/聯合治療模式
    • 第Ⅰ相的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Pantarhei Bioscience BV:藥物簡介

  • (prasterone + estradiol acetate + progesterone)
  • (oxytocin + estrogen)
  • esterol
  • BLACE
  • T-2

Pantarhei Bioscience BV:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Pantarhei Bioscience BV:最近的開發平台形勢

Pantarhei Bioscience BV:開發暫停中的計劃

Pantarhei Bioscience BV:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07458CDB

Summary

Global Markets Direct's, 'Pantarhei Bioscience BV - Product Pipeline Review - 2015', provides an overview of the Pantarhei Bioscience BV's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pantarhei Bioscience BV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Pantarhei Bioscience BV including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Pantarhei Bioscience BV's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Pantarhei Bioscience BV's pipeline products

Reasons to buy

  • Evaluate Pantarhei Bioscience BV's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Pantarhei Bioscience BV in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Pantarhei Bioscience BV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Pantarhei Bioscience BV and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pantarhei Bioscience BV
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Pantarhei Bioscience BV and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Pantarhei Bioscience BV Snapshot
    • Pantarhei Bioscience BV Overview
    • Key Information
    • Key Facts
  • Pantarhei Bioscience BV - Research and Development Overview
    • Key Therapeutic Areas
  • Pantarhei Bioscience BV - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Pantarhei Bioscience BV - Pipeline Products Glance
    • Pantarhei Bioscience BV - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Pantarhei Bioscience BV - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Pantarhei Bioscience BV - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Pantarhei Bioscience BV - Drug Profiles
    • (prasterone + estradiol acetate + progesterone)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (oxytocin + estrogen)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • esterol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BLACE
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • T-2
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Pantarhei Bioscience BV - Pipeline Analysis
    • Pantarhei Bioscience BV - Pipeline Products by Target
    • Pantarhei Bioscience BV - Pipeline Products by Route of Administration
    • Pantarhei Bioscience BV - Pipeline Products by Molecule Type
    • Pantarhei Bioscience BV - Pipeline Products by Mechanism of Action
  • Pantarhei Bioscience BV - Recent Pipeline Updates
  • Pantarhei Bioscience BV - Dormant Projects
  • Pantarhei Bioscience BV - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Pantarhei Bioscience BV, Key Information
  • Pantarhei Bioscience BV, Key Facts
  • Pantarhei Bioscience BV - Pipeline by Indication, 2015
  • Pantarhei Bioscience BV - Pipeline by Stage of Development, 2015
  • Pantarhei Bioscience BV - Monotherapy Products in Pipeline, 2015
  • Pantarhei Bioscience BV - Combination Treatment Modalities in Pipeline, 2015
  • Pantarhei Bioscience BV - Partnered Products in Pipeline, 2015
  • Pantarhei Bioscience BV - Partnered Products/ Combination Treatment Modalities, 2015
  • Pantarhei Bioscience BV - Out-Licensed Products in Pipeline, 2015
  • Pantarhei Bioscience BV - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Pantarhei Bioscience BV - Phase III, 2015
  • Pantarhei Bioscience BV - Phase II, 2015
  • Pantarhei Bioscience BV - Phase I, 2015
  • Pantarhei Bioscience BV - Preclinical, 2015
  • Pantarhei Bioscience BV - Pipeline by Target, 2015
  • Pantarhei Bioscience BV - Pipeline by Route of Administration, 2015
  • Pantarhei Bioscience BV - Pipeline by Molecule Type, 2015
  • Pantarhei Bioscience BV - Pipeline Products by Mechanism of Action, 2015
  • Pantarhei Bioscience BV - Recent Pipeline Updates, 2015
  • Pantarhei Bioscience BV - Dormant Developmental Projects,2015
  • Pantarhei Bioscience BV, Other Locations

List of Figures

  • Pantarhei Bioscience BV - Pipeline by Top 10 Indication, 2015
  • Pantarhei Bioscience BV - Pipeline by Stage of Development, 2015
  • Pantarhei Bioscience BV - Monotherapy Products in Pipeline, 2015
  • Pantarhei Bioscience BV - Combination Treatment Modalities in Pipeline, 2015
  • Pantarhei Bioscience BV - Pipeline by Top 10 Target, 2015
  • Pantarhei Bioscience BV - Pipeline by Top 10 Route of Administration, 2015
  • Pantarhei Bioscience BV - Pipeline by Top 10 Molecule Type, 2015
  • Pantarhei Bioscience BV - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top